JP2004512824A5 - - Google Patents

Download PDF

Info

Publication number
JP2004512824A5
JP2004512824A5 JP2002509377A JP2002509377A JP2004512824A5 JP 2004512824 A5 JP2004512824 A5 JP 2004512824A5 JP 2002509377 A JP2002509377 A JP 2002509377A JP 2002509377 A JP2002509377 A JP 2002509377A JP 2004512824 A5 JP2004512824 A5 JP 2004512824A5
Authority
JP
Japan
Prior art keywords
polypeptide
sequence
seq
antigen
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002509377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004512824A (ja
Filing date
Publication date
Priority claimed from US09/614,124 external-priority patent/US6630574B1/en
Priority claimed from US09/651,563 external-priority patent/US6914132B1/en
Priority claimed from US09/658,824 external-priority patent/US6746846B1/en
Priority claimed from US09/671,325 external-priority patent/US6667154B1/en
Priority claimed from US09/702,705 external-priority patent/US6504010B1/en
Priority claimed from US09/736,457 external-priority patent/US6509448B2/en
Priority claimed from US09/849,626 external-priority patent/US20020197669A1/en
Application filed filed Critical
Priority claimed from PCT/US2001/022058 external-priority patent/WO2002004514A2/fr
Publication of JP2004512824A publication Critical patent/JP2004512824A/ja
Publication of JP2004512824A5 publication Critical patent/JP2004512824A5/ja
Pending legal-status Critical Current

Links

JP2002509377A 2000-07-11 2001-07-10 肺癌の治療および診断のための組成物および方法 Pending JP2004512824A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/614,124 US6630574B1 (en) 1999-06-30 2000-07-11 Compositions and methods for the therapy and diagnosis of lung cancer
US09/651,563 US6914132B1 (en) 1999-06-30 2000-08-29 Compositions and methods for the therapy and diagnosis of lung cancer
US09/658,824 US6746846B1 (en) 1999-06-30 2000-09-08 Methods for diagnosing lung cancer
US09/671,325 US6667154B1 (en) 1999-06-30 2000-09-26 Compositions and methods for the therapy and diagnosis of lung cancer
US67741900A 2000-10-06 2000-10-06
US09/702,705 US6504010B1 (en) 1999-06-30 2000-10-30 Compositions and methods for the therapy and diagnosis of lung cancer
US09/736,457 US6509448B2 (en) 1999-06-30 2000-12-13 Compositions and methods for the therapy and diagnosis of lung cancer
US09/849,626 US20020197669A1 (en) 2000-12-13 2001-05-03 Compositions and methods for the therapy and diagnosis of lung cancer
PCT/US2001/022058 WO2002004514A2 (fr) 2000-07-11 2001-07-10 Compositions et procedes pour le traitement et le diagnostic du cancer du poumon

Publications (2)

Publication Number Publication Date
JP2004512824A JP2004512824A (ja) 2004-04-30
JP2004512824A5 true JP2004512824A5 (fr) 2008-10-16

Family

ID=27575493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509377A Pending JP2004512824A (ja) 2000-07-11 2001-07-10 肺癌の治療および診断のための組成物および方法

Country Status (6)

Country Link
EP (1) EP1343886A2 (fr)
JP (1) JP2004512824A (fr)
AR (1) AR031250A1 (fr)
AU (1) AU2002218770A1 (fr)
CA (1) CA2415544A1 (fr)
WO (1) WO2002004514A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
EP1250426A2 (fr) * 1999-12-01 2002-10-23 Genentech Inc. Polypeptides transmembranaires et secretes et les acides nucleiques codant ceux-ci
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
ZA200204907B (en) 2001-06-26 2003-03-03 Univ Nat Taiwan Collapsin Response Mediator Protein-1.
EP1543018A4 (fr) * 2002-08-14 2006-10-25 Lg Life Sciences Ltd Familles de genes associees au cancer du foie
JP2006519582A (ja) * 2002-09-26 2006-08-31 ジェネンテック・インコーポレーテッド 乾癬の治療のための新規組成物と方法
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US7449291B1 (en) * 2003-01-13 2008-11-11 University Of Washington Methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C
WO2004070058A1 (fr) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methodes et compositions permettant de prevoir, diagnostiquer, pronostiquer, prevenir et traiter des broncho-pneumopathies chroniques obstructives
CA2520512A1 (fr) * 2003-03-24 2004-10-07 Corixa Corporation Methodes, compositions et trousses pour la detection et pour la surveillance d'un cancer du poumon
ATE528397T1 (de) 2003-08-08 2011-10-15 Perseus Proteomics Inc Bei krebs überexprimiertes gen
EP1668354A2 (fr) * 2003-09-24 2006-06-14 Oncotherapy Science, Inc. Methode de diagnostic du cancer du sein
JP4428995B2 (ja) 2003-12-03 2010-03-10 関東化学株式会社 金属膜のエッチング液組成物
CA2555509A1 (fr) * 2004-01-27 2005-07-27 Compugen Usa, Inc. Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
KR101300544B1 (ko) 2004-03-31 2013-09-02 히로유키 아브라타니 항ｒｏｂｏ1항체를 이용하는 암의 진단 및 치료
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
EP1915622A2 (fr) * 2005-07-29 2008-04-30 Oncotherapy Science, Inc. Criblage et methode therapeutique anti-nsclc ciblant le complexe cda1-kntc2
WO2008076127A1 (fr) * 2006-12-21 2008-06-26 Intradigm Corporation Compositions inhibitrices de polynucléotide et procédés de traitement du cancer
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
PT2186889E (pt) 2007-08-20 2015-06-17 Oncotherapy Science Inc Péptido cdca1 e agente farmacêutico que o compreende
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2433964A4 (fr) * 2009-05-22 2013-09-11 Univ Okayama Nat Univ Corp Peptide induisant une réponse immunitaire spécifique contre xage-1b et son utilisation
EP2872532A4 (fr) * 2012-07-10 2016-04-13 Oncotherapy Science Inc Peptides épitopes du cdca1 pour cellules th1 et vaccins les contenant
CN114102955B (zh) * 2020-08-31 2024-05-07 天津科技大学 一种采用常温发泡技术制备发泡聚乳酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139800A (ja) * 1996-11-15 1998-05-26 Santen Pharmaceut Co Ltd シェーグレン症候群治療剤
ID27813A (id) * 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
WO2000055375A1 (fr) * 1999-03-17 2000-09-21 Alphagene, Inc. Proteines secretees et polynucleotides les codant
MXPA02000192A (es) * 1999-06-30 2004-08-12 Corixa Corp Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.

Similar Documents

Publication Publication Date Title
JP2004512824A5 (fr)
JP2005504513A5 (fr)
JP2006515749A5 (fr)
JP2004512022A5 (fr)
JP2002532093A5 (fr)
RU2002121771A (ru) Композиции и способы для терапии и диагностики рака предстательной железы
JP2002542157A5 (fr)
CN113912710B (zh) 抗新型冠状病毒n蛋白的单克隆抗体及其应用
JP2002515763A (ja) Ｅｈｒｌｉｃｈｉａ感染の診断および処置のための化合物および方法
RU2006134631A (ru) Иммуногенные композиции против chlamidia pneumoniae
EP2186884A2 (fr) Anticorps monoclonaux contre des antigènes du noyau de CHV
WO2003037267B1 (fr) Compositions et methodes de traitement et de diagnostic du cancer des poumons
US10408840B2 (en) Method for predicting clinical effect of immunotherapy
WO2001079274B1 (fr) Antigenes de la tuberculose
EP3239176B1 (fr) Anticorps anti-gip actif
JP2008515388A5 (fr)
AU2016262669B2 (en) A novel macadamia allergen
CA2287545A1 (fr) Polypeptides de la famille ma et anticorps anti-ma
US5780298A (en) DNA encoding the sn-RNP-A antigen and fragments thereof
WO1999005175A3 (fr) Ligands, notamment anticorps, a reactivite contre les cellules endocrines
JP2005507648A5 (fr)
JP2005535287A5 (fr)
JP2008509659A5 (fr)
RU2002128922A (ru) Композиции и способы для лечения и диагностики рака легких
JP2005522209A5 (fr)